Allied Biotechnology to Change Direction
- Share via
IRVINE — Allied Biotechnology International Inc. said Tuesday that its shareholders voted to change the direction of the company from biotechnology to water projects.
Shareholders also elected E.G. Marchi as president and Michael Roth and Daniel Kelly as directors. They also voted to increase authorized shares to 250 million from 25 million and to effect a 25-to-1 reverse split of the shares outstanding.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
